Insulet | Efectivo Y Equivalentes



Cash And Equivalent Cambio Fecha
Abbott USD 7.62B 58M 2024-12
Align Technology USD 1.04B 1.95M 2024-12
AtriCure USD 122.72M 7.61M 2024-12
Avanos Medical USD 107.7M 18.7M 2024-12
Baxter International USD 1.76B 344M 2024-12
Becton, Dickinson and Co. USD 711M 1.01B 2024-12
Boston Scientific USD 414M 2.09B 2024-12
Cardinal Health USD 3.81B 943M 2024-12
Cooper Companies USD 100.9M 6.7M 2025-01
Dexcom USD 606.1M 15.1M 2024-12
Edwards Lifesciences USD 3.05B 631.2M 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
Globus Medical USD 784.44M 161.67M 2024-12
ICU Medical USD 308.57M 3.95M 2024-12
Insulet USD 820M 133.5M 2024-12
Integra LifeSciences USD 246.38M 31.22M 2024-12
J&J USD 6.12B 1.28B 2024-12
Masimo USD 177.6M 19.1M 2024-12
Medtronic USD 1.24B 154M 2025-01
Merit Medical Systems USD 376.72M 146.41M 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Solventum Corp 762M 10M 2024-12
Stryker USD 3.65B 198M 2024-12
Tandem Diabetes Care USD 69.23M 20.2M 2024-12
Teleflex USD 290.19M 46.95M 2024-12
West Pharmaceutical Services USD 484.6M 6.3M 2024-12
Zimmer Biomet Holdings USD 525.5M 43.5M 2024-12



Insulet Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.